Document Type : Original Article

Authors

1 Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

2 Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Chamran Cardiovascular Medical and Research Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

BACKGROUND: Heart failure (HF) is considered the leading cause of cardiac-related morbidity and mortality during pregnancy. Peripartum cardiomyopathy (PPCM) presents diagnostic challenges, often mirroring dilated cardiomyopathy (DCM). The aim of the study is to evaluate echocardiographic features, including global and segmental longitudinal strain values, in pregnant women with a history of newly diagnosed left ventricular systolic dysfunction (LVSD) in the third trimester of pregnancy.
METHODS: This cross-sectional study, conducted in two referral cardio-obstetric clinics in Isfahan, Iran, enrolled pregnant women with newly diagnosed LV systolic dysfunction in the third trimester of pregnancy. A multidisciplinary pregnancy heart team assessed the patients. Reevaluation of patients and advanced echocardiographic investigation, including speckle tracking echocardiography (STE), were performed at least six months after delivery.
RESULTS: The study included 26 pregnant women. Baseline characteristics revealed varying NYHA functional classes and etiologies, including DCM or non-dilated LV cardiomyopathy and PPCM. Undiagnosed DCM with exacerbation during pregnancy or non-dilated LV cardiomyopathy were the most probable causes for LV systolic dysfunction (65.4%). In five cases, peripartum cardiomyopathy was more relevant. The mean global longitudinal strain (GLS) was -16.94% and -13.95% in PPCM and DCM, respectively. Significantly different regional longitudinal strain numbers among different LV segments in PPCM were observed (P=.042), whereas the segmental strain in DCM patients did not differ.
CONCLUSION: When LVSD is discovered late in pregnancy, it is not easy for the authors to differentiate between peripartum cardiomyopathy and other cardiomyopathies. Advanced echocardiographic techniques, particularly GLS analysis, may be valuable in differentiating between these conditions.

Keywords

1.    Elkayam U, Goland S, Pieper PG, Silversides C. High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol. 2016;68(4):396-410. https://doi.org/10.1016/j.jacc.2016.05.048
2.    Dorn GW. The fuzzy logic of physiological cardiac hypertrophy. Hypertension. 2007;49(5):962-70. https://doi.org/10.1161/hypertensionaha 106.079426
3.    Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol. 2008;22(5):801-23. https://doi.org/10.1016/j.bpobgyn.2008.06.005
4.    Anthony J, Sliwa K. Decompensated Heart Failure in Pregnancy. Card Fail Rev. 2016 May;2(1):20-6. 
https://doi.org/10.15420/cfr.2015:24:2
5.    Bollen IA, Van Deel ED, Kuster DW, Van Der Velden J. Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart. Front Physiol. 2015 Jan 15;5:531. https://doi.org/10.3389/fphys.2014.00531
6.    Rodriguez Ziccardi M, Siddique MS. Peripartum Cardiomyopathy. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK482185/
7.    Potter E, Marwick TH. Assessment of Left Ventricular Function by Echocardiography: The Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction. JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):260-74. https://doi.org/10.1016/j.jcmg.2017.11.017
8.    Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-241. https://doi.org/10.1093/eurheartj/ehy340
9.    Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation. 2010 May 25;121(20):2176-82.
https://doi.org/10.1161/circulationaha.109.931220
10.    Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007 Feb 9;128(3):589-600. https://doi.org/10.1016/j.cell.2006.12.036
11.    Briasoulis A, Mocanu M, Marinescu K, Qaqi O, Palla M, Telila T, et al. Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy. Echocardiography. 2016 Sep;33(9):1354-60. 
https://doi.org/10.1111/echo.13277
12.    Davis EM, Ewald G, Givertz MM, Rajagopalan N, Cooper Jr LT, Briller J, et al, Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy. Am J Perinatol. 2019 Apr;36(5):476-83. https://doi.org/10.1055/s-0038-1669439
13.    Ajmi H, Abid D, Milouchi S, Louati D, Sghaier A, Choura D, et al. Interest of speckle tracking in the detection of cardiac involvement in pregnant women with hypertensive disorder. Pregnancy Hypertens. 2018 Jan;11:136-41. https://doi.org/10.1016/j.preghy.2017.10.008
14.    Ando T, Kaur R, Holmes AA, Brusati A, Fujikura K, Taub CC. Physiological adaptation of the left ventricle during the second and third trimesters of a healthy pregnancy: a speckle tracking echocardiography study. Am J Cardiovasc Dis. 2015 Aug 1;5(2):119-26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539098/
15.    Cong J, Fan T, Yang X, Squires JW, Cheng G, Zhang L, et al. Structural and functional changes in maternal left ventricle during pregnancy: a three-dimensional speckle-tracking echocardiography study. Cardiovasc Ultrasound. 2015 Jan 27;13:6. https://doi.org/10.1186/1476-7120-13-6
16.    Bortnick AE, Lama von Buchwald C, Hasani A, Liu C, Berkowitz JL, Vega S, et al. Persistence of abnormal global longitudinal strain in women with peripartum cardiomyopathy. Echocardiography. 2021;38(6):885-91. https://doi.org/10.1111/echo.15071